Previous Article | Next Article ![]()
Applied and Environmental Microbiology, August 2005, p. 4850-4855, Vol. 71, No. 8
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.8.4850-4855.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Meir Broza,2
Yechezkel Kashi,1* and
Eyal Shimoni1*
Department of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel,1 Department of Biology, Faculty of Sciences and Science Education, University of Haifa, Oranim, Tivon 36006, Israel2
Received 6 December 2004/ Accepted 3 March 2005
|
|
|---|
|
|
|---|
Diarrheal diseases, including cholera, are one of the two main causes of infant and child mortality in developing countries, claiming the lives of >3 million children every year (4). The need to provide immediate assistance to the population at risk led the World Health Organization (WHO) to develop oral rehydration therapy (ORT), enabling the survival of the affected patients through the course of the disease. The life-saving effect of oral rehydration solution (ORS) is achieved primarily by maintaining the electrolyte balance through stimulation of the absorption of sodium from the small intestine (7). The solutions, however, fail to prevent or reduce to a significant extent the symptoms of cholera. In controlled studies, oral rehydration therapy is very effective in reducing mortality (1). Unfortunately, the level of use of oral rehydration therapy has remained low in both developing and developed countries, even though it has been publicized through health education efforts (2, 3, 27). In developing countries, several factors are responsible for the poor acceptance of oral rehydration therapy. There is a perception that oral rehydration is not effective because it does not reduce the manifestations of diarrhea, such as the loss of fluid in feces, or the duration of diarrheal illness (9, 16). Moreover, the glucose-based ORS recommended by the World Health Organization may paradoxically increase fecal fluid loss. Because of these limitations, there has been a substantial impetus to develop a better oral rehydration therapy (33). As ORS is not a prescription drug, it may be used as the forefront treatment of cholera, where timely antibiotic treatment or intravenous rehydration may not be available. This is especially true in regions where medical care is inaccessible within a reasonable time. In these cases, the immediate use of ORS may be lifesaving.
Starch is one of the most abundant carbohydrates in plants. Some of the starch ingested by humans escapes digestion in the small intestine. This fraction was given the name resistant starch (RS). Starch in plants is packaged in granules and can be fractionated into two glucose homopolysaccharide macromolecules: amylose and amylopectin. For most native starches, X-ray diffraction yields two types of spectral patterns, A-type (most cereals) and B-type (tuber) crystallites (15). RS is classified into four types (10, 11). Type I (RSI) is physically inaccessible, because the intact plant structure hinders enzymatic digestion. RSII is a native granular starch with a highly dense crystalline structure that prevents enzymatic digestion. RSIII results from pasted starch formed by a hydrothermal procedure, followed by retrogradation. RSIV is a chemically modified starch. Although not digested in the small intestine, RS may be fermented by the microbiota in the large bowel. The crystalline-resistant structures in RSII and RSIII are resistant to mammalian amylases but can be degraded by microbial fermentation. Among its many beneficial biological effects, RS is known as a source of short-chain fatty acids (SCFA), due to RS fermentation in the colon. Since SCFA are known to enhance ion adsorption in the colon, the addition of starch was considered for ORS improvement.
Recently, new endeavors were made to improve ORT by changing the ORS composition. The mechanisms behind the beneficial effects of ORS treatment on human physiology have been studied extensively. However, very little is known about the effects of ORS on the behavior and survival of diarrhea-producing microbes. Beneficial effects of starch-based ORS were proven for the treatment of cholera (26). It is very likely that several mechanisms are responsible for the overall beneficial effects of adding resistant starch to the ORS. Clinical trials with such a mixture showed a marked improvement in symptom manifestation, in addition to the ORS lifesaving effect (26). The hypothesis raised by Ramakrishna et al. (26) was that some of the beneficial effect of the ORS, with its high-amylose cornstarch, was due to SCFA formation by the colon microbiota, thus changing the fluid balance in the colon.
It is known that V. cholerae adheres to different surfaces such as the human lumen, chironomid egg masses (6), chitin (8), zooplankton (20), and other surfaces. For some surfaces, V. cholerae biofilm formation and adherence have been shown to influence its survival and possibly its infective potential (39). The property of V. cholerae to adhere to various surfaces is related to environmental survival of the bacteria (8), as well as to its colonization of the intestine (21, 28, 37). We therefore set out to examine the interactions between V. cholerae and starch. This can explain, at least in part, the beneficial effect of starch-containing ORS in the treatment of cholera compared to the treatment with regular ORS.
|
|
|---|
Bacterial culturing.
All strains, except L. monocytogenes, were grown in 50 ml of rich medium (Luria-Bertani [LB] medium) at 37°C in a 250-ml flask with shaking (200 rpm) for 6 to 8 h. Where appropriate, the culture medium was supplemented with antibiotics at the following concentrations: ampicillin, 100 mg · liter1; kanamycin, 30 mg · liter1; and streptomycin, 30 mg · liter1. L. monocytogenes was cultured in 50 ml of brain heart (BH) medium (32) supplemented with 5 mg · liter1 erythromycin in a 250-ml flask with shaking (200 rpm) at 30°C for 6 to 8 h.
V. cholerae, as well as the other strains used, was distributed into aliquots containing preservation medium (final glycerol concentration, 20%). The aliquots were kept at 80°C until use. Cultures were reared from the frozen stock by inoculation of 50 ml of LB or BH medium with the content of one aliquot (and supplementation with antibiotics if used). The cultures were grown for 18 h at 37°C or 30°C with aeration. The cells were harvested by centrifugation (16,000 x g; 5 min).
Plasmid purification and electroporation.
E. coli harboring a green fluorescent protein (GFP)-expressing plasmid (pSMC2 or pVSP61TIR) was grown overnight in LB medium containing the appropriate antibiotic. Plasmids were purified with a plasmid purification kit (QIAprep miniprep kit; QIAGEN, Hilden, Germany) and kept at 20°C until use. pSMC2 in E. coli DH5
was a kind gift from R. Kolter (36). pVSP61TIR in E. coil JM109 was a kind gift from S. E. Lindow (23).
Plasmid transformation was done by electroporation as described by Hamashima et al. (18). After electroporation, the cells were grown for 1 h with agitation at 37°C and then streaked on plates with the appropriate antibiotic. Green fluorescent colonies were isolated.
Microscopy.
Epifluorescence microscopy was done with a Zeiss Axioscop II equipped with a UV Lamp (Nikon). A filter set with an excitation wavelength of 490 nm and an emission wavelength of 520 nm was used. Digital pictures were taken with a Nikon Coolpix 995 digital camera. Pictures were digitally processed with Photoshop 7.0 (Adobe).
Composition of the ORS.
The modified ORS composition was 3.5 g · liter1 of NaCl, 2.5 g · liter1 NaHCO3, and 1.5 g · liter1 of KCl (WHO formula) (24) without glucose and was used in the standard adhesion experiments. Whenever sugars or salts were added, their final concentration was 111 mM · liter1 (equivalent to the WHO recommended glocuse concentration), as follows: lactose, 38 g · liter1; sucrose, 38 g · liter1; trehalose, 38 g · liter1; glucose, 20 g · liter1; fructose, 20 g · liter1; maltose, 38 g · liter1; xylose, 16.5 g · liter1; maltodextrins DE19 (for dextrose equivalent 19) and DE6, 50 g · liter1; and NaCl, 6.5 g · liter1 (additional). All chemicals were of analytical grade.
Starch degradation activity and starch plates.
The starch plate assay employed a solid medium (LB or BH) prepared with 2% (wt/vol) soluble starch from potatoes (Sigma Chemical Co.). Bacteria were streaked on the agar. Plates were incubated at 37°C for 48 h. A solution of 2% (wt/vol) potassium iodide and 0.6125% (wt/vol) iodine was added to the plates to visualize zones of starch hydrolysis.
Starch chemophysical analyses. (i) Size distribution by light scattering.
The average granule diameter for each starch type was determined by using a laser diffraction particle size analyzer (LS 230; Coulter). The test was performed following the manufacturer's instructions. Data were analyzed using the LS Coulter 230 software package, version 2.11a.
(ii) Chemical tests and protein content.
The protein contents of each starch type were determined at the Miloda Laboratories, Milout Industrial Park, Israel (a certified food testing laboratory) according to AOAC International official method 997.06.
Starch preparation.
The following types of starch granules were used: corn, wheat, soluble starch from potato, rice (Sigma), high-amylose maize starch, and waxy cornstarch (National Starch & Chemical). All native starches were by definition resistant starch type II. Each starch was equilibrated in the test medium, shaken well, and mixed.
Adhesion procedure.
The bacteria, following overnight growth, were harvested by centrifugation and washed three times with 1 ml of the modified ORS. ORS with starch was inoculated with the washed bacterial cells to give an estimated final concentration of 105 cells · ml1 with 10% starch. After the starch and the cells were mixed for a short period of time (2 min overall time), the starch granules were removed by centrifugal sedimentation (320 x g for 30 s). The number of the remaining bacteria (in the upper fluid) was enumerated by being plated on LB agar or BH agar, with the appropriate antibiotic, if used. All experiments were repeated at least three times with fresh bacteria, starch, and ORS.
The use of controls passing through the same procedure overruled the possibility that the low rate and short centrifugation time were causes for the reduction in CFU recorded. Light microscopy was used to verify the removal of starch granules from the supernatant. The other explanation, attributing the reduction in CFU recorded to the combination of centrifugation and suspended particles, was shown to be irrelevant when particles of soluble starch were used. Those particles did not alter the number of CFU recorded compared with the control.
When slides was prepared for fluorescent microscopy, GFP-tagged bacteria were prepared as described above. In addition, the starch granules were further washed three times after the initial sedimentation with fresh ORS before they were viewed under the fluorescent microscope.
|
|
|---|
![]() View larger version (17K): [in a new window] |
FIG. 1. Immediate adhesion of V. cholerae to different starches. Vibrio cholerae O1 was grown in 50 ml of Luria-Broth liquid medium in a 250-ml flask with agitation for 16 to 18 h at 37°C. The bacteria were harvested by centrifugation (16,000 x g for 5 min) and washed three times with modified ORS without starch. The bacteria were then diluted to a final concentration of 106 CFU · ml1. The starch-containing ORS (preequilibrated) was mixed at a 9:1 ratio to give a final concentration of 10% starch and approximately 105 CFU · ml1 (106 CFU to 1 g of starch). The mixture was rotated on an axial spinning agitator, and samples were drawn after 2 min. The samples were spin centrifuged for 30 s at 320 x g. A 100-µl sample of the supernatant was serially diluted and plated on Luria agar plates; after 24 h incubation at 37°C, the numbers of CFU were recorded. Controls containing modified ORS without starch were used to normalize the results (P < 0.05). a, b, and c indicate significant differences (P < 0.05).
|
|
View this table: [in a new window] |
TABLE 1. Chemophysical characteristics of the starches used
|
![]() View larger version (43K): [in a new window] |
FIG. 2. Adhesion of GFP-tagged V. cholerae to cornstarch. Vibrio cholerae O1, tagged with a plasmid encoding GFP, was grown and mixed with ORS containing cornstarch as described in the legend to Fig. 1. The starch granules were washed three times with the modified ORS and then viewed under light and fluorescence microscopes (magnification, x1,000). Images were captured by digital camera and processed using Adobe Photoshop 7.0. The left panel shows starch granules with the GFP-tagged bacteria under UV light. The right panel shows the same field under normal light.
|
![]() View larger version (20K): [in a new window] |
FIG. 3. Effect of low-molecular-weight solutes on V. cholerae adhesion to cornstarch. Vibrio cholerae O1 was grown and mixed with ORS containing cornstarch as described in the legend to Fig. 1, except that the ORS used contained 111 mmol · liter1 of either glucose, sucrose, trehalose, sodium chloride, xylose, fructose, maltose, or lactose or 50 g · liter1 dextrins (DE19 and DE6). The mixture was rotated on an axial spinning agitator, and samples were drawn after 2 min. The samples were spin centrifuged for 30 s at 320 x g. A 100-µl sample of the supernatant was serially diluted and plated on Luria agar plates; after 24 h incubation at 37°C, the numbers of CFU were recorded. Controls containing modified ORS without starch were used to normalize the results (P < 0.05). a, b, and c indicate significant differences (P < 0.05).
|
|
View this table: [in a new window] |
TABLE 2. Average adhesion of different bacteria to corn starch granule
|
|
|
|---|
Adhesion experiments with various starches demonstrated that V. cholerae adheres to starch granules, to cornstarch in particular. We report marked differences in adhesion of V. cholerae to starches from various sources. However, we cannot point to specific compositional characteristics of cornstarch that may be related to the high adhesion to this specific starch. It should be noted that all of the native starches are resistant starch type II (by definition), which is likely to escape digestion in the intestine. Thus, these findings point at a new mode of action, explaining starch function in ORS, and may be utilized to improve the current treatment of cholera.
An interesting question is whether the adhesion is a nonspecific physical phenomenon or an interaction between specific ligands. A partial answer can be found in the observation that the adhesion to cornstarch is affected by low-molecular-weight solutes, in particular, sugars. At least two possible explanations can account for these findings. The first explanation attributes the phenomena to metabolic regulation. It is supported by the interesting observation that prevention of adhesion by a solute was related to the ability of the bacteria to utilize the solute as an energy source. It is known that V. cholerae reacts to starvation by producing proteins that are translocated to the cell surface (35). Glucose has been identified as a signal that could modulate the expression of virulence factors in V. cholerae (31), and a similar mechanism may modulate adhesion to starch granules. Further support for the relation between starch metabolism and the adhesion can be found in the adhesion of other pathogen strains. The adhesion to starch, among the small panel of pathogenic bacterial strains, seems to be unique to those that are able to utilize it, at least as judged by the screen performed in this study.
The second possible explanation for the repressive role of several sugars on the adhesion is that of competition between the starch and the solute for specific binding sites found on the bacteria. It is well documented that pathogenic bacteria, including V. cholerae, express lectins on their surface to adhere to the host tissues (29). In addition, V. cholerae expresses a maltodextrin (a product of the degradation of starch)-binding protein that was recently cloned and characterized (13). Of particular interest is the mannose- and glucose-specific lectin isolated from the O1 strain by Sasmal et al. (30). Thus, it is possible that the adhesion-inhibitory effect of some of the sugars tested is due to their competitive binding to lectin-binding sites involved in the adhesion to starch granules. In this context, the fact that maltose was shown to affect the virulence of V. cholerae (22) may indicate an additional benefit of starch, namely, virulence repression by an available carbon source.
The adhesion to starch described here is an interesting feature of V. cholerae as it might be related to its survival in the environment during and between epidemics. Starch is an abundant natural polymer. The ability to utilize starch, as well as other complex polymers, like the sugar-containing gelatinous matrix surrounding the chironomid egg masses (17), indicates that this microorganism relies on several complex substrates for its survival. It has been speculated that the appearance of high numbers of V. cholerae is correlated to algal blooms (25), yet algae are known to contain large quantities of starch. In addition, V. cholerae could be isolated from plants (Eichhornia crassipes) found in river water (5). Therefore, the ability to utilize starch as well as the ability to adhere to it can contribute to the utilization of this food source in the aquatic environments.
The results presented here are of high importance, as they may explain several unresolved issues in the matter of the beneficial effects attributed to starch incorporation into ORS. It is well documented that starch incorporation into ORS does not benefit all cases of diarrhea. In fact, the beneficial effects of starch on ORT were shown only when the disease was caused by V. cholerae. Even in the case of starch incorporation in ORS treatment of cholera, a wide range of results were obtained, ranging from no effect to marked improvement in symptoms and reduction in the duration of the disease (19, 26, 38). Our findings shed light on these puzzling results and may explain, at least partially, the confusing data. We hypothesize that during diarrhea, positive effects such as SCFA formation, attributed to the regular consumption of resistant starch, disappear. These well-documented effects are intimately linked to the natural microflora of the gut (34), which is washed out during the severe fluid loss. Thus, beneficial effects from starch, when incorporated into ORS, are either related to its physical properties and its interaction with the human body or due to the diarrhea-causing-agent interactions with the starch. As starch incorporation seems to be beneficial in a manner related to the causative agent (12), we claim that the latter prevails. When no interaction exists between the causative agent and the starch, starch incorporation into ORS has no significant effect. In contrast, V. cholerae interacts with starch, resulting in a marked effect on the ORT. In accordance with our findings, we suggest that adhesion to the starch granules might compete with sites in the lumen during colonization. We suggest a model where V. cholerae adheres to the ungelatinized starch granules, which are practically indigestible in the intestine and are secreted from the intestine. It is therefore possible that in this way that the adhering V. cholerae is removed from the intestine. Yet, as is evident from our results, starch type also plays a pivotal role in the strength of the interaction. In addition, the microflora found in the gut most probably utilizes the glucose found in the ORS. As showed in this study, the presence of glucose prevents the adhesion of V. cholerae to the starch granules. These observations imply that starch type incorporated into the ORS, as well as the ORS composition, should be chosen carefully.
The points addressed in this article can partially explain the wide range of results obtained in the clinical trails in different starch-containing ORS formulas. Further studies are under way to identify the nature of the adherence factors, their regulation, and their possible effects on cholera toxin expression.
H.G. and O.N.-M. contributed equally to this work. ![]()
Present address: Uniformed Services University of the Health Sciences, Department of Microbiology and Immunology, 4301 Jones Bridge Rd., Bethesda, MD 20814. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»